检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]郑州市儿童医院血液肿瘤科,河南郑州450000
出 处:《医药前沿》2016年第21期46-48,共3页Journal of Frontiers of Medicine
摘 要:目的:研究急性淋巴细胞白血病大剂量甲氨蝶呤化疗中护肝药物应用的必要性。方法:收集本院2012年1月~2015年1月4年间156例在本院给予大剂量甲氨蝶呤化疗患儿化疗期间ALT、AST、ALP、TBA、TBil等肝酶的变化,按化疗初即给予护肝药物和不给予护肝药物分为两组,研究两组患儿化疗后转氨酶的转归。结果:两组患儿化疗后ALT、AST、ALP、TBA、TBil等肝酶的变化无明显统计学差异(P〉0.05)。结论:急性淋巴细胞白血病大剂量甲氨蝶呤化疗期间给予护肝药物治疗不能明显降低化疗药物肝损害程度,因此大剂量甲氨蝶呤化疗可不常规给予护肝药物治疗。Objective To study the necessity of application of lump drugs of high-dose methotrexate on liver in children with acute lymphoblastic leukemia.Methods From Jan 2012 to Jan 2015,156 hospitalized children with acute lymphoblastic leumia were enrolled in the study and divided into two groups: protect liver of the beginning of the chemotherapy(76 cases) and no protect liver of the beginning of the chemotherapy( 80 cases), tio study the viriation of the function of liver between the pre and post chemotherapy.Results There were no ststistical differences between the levels of ALT、AST、ALP、γ-GT in both groups at post chemotherapy.Conclusion Acute lymphocytic leukemia during high-dose methotrexate chemothrexate chemotherapy to protect liver medicine not significantly reduce chemothereapy drugs liver damage degree, so the high-dose mrthotreate chemotherapy is not normal to protect liver medicine.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229